Further data are presented concerning the unusual hemodynamic effects of 1 -hiydraziniophthalazine. Previous observations demonstrating a marked increase in cardiac output in noimotensive subjects are confirmed in hypertensive patients. The splanchnic vascular bed is one of the sites of increased blood flow. The similarity between the hemodynamic effects of 1-bydr.azinophthalazine and pyirogens is pointed out and the pharmacologic basis for the clinically observed additive effects of 1-1yd)rdazinol)lpthalazine an(d hexamethonium is (liscusse(l. G ROSS and his co-workers, in animals, ' and Reubi, in man,2 were the first to demonstrate that 1-hydrazinophthalazine (Apresoline) produces a reduction of arterial pressure and simultaneously an increase in renal blood flow. Since then considerable attention has been directed toward the further elucidation of the hemodynamic effects of this agent. Moyer and his associates, working with dogs, noted a marked increase in cardiac output and decrease in total peripheral resistance following administration of 1-hydrazinophthalazine.3 This observation was confirmed in normal and hypertensive pregnant women by Assali and his co-workers using the ballistocardiographic method4 and in normal subjects by Wilkinson and his associates using the intra-
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In respect to blood flow through vascular areas other than the kidney, coronary blood flow was found to be increased in rabbits' and in the dog heart-lung preparation,' but has not been studied in man. Hafkeinschiel and his associates in a preliminary report observed that blood flow through the cerebral vessels was essentially unchanged in man,7 while skin blood flow as measured in the toes did not increase significantly.8 In view of the apparently greater elevation of cardiac output than could be explained on the basis of the increases observed in renal and coronary flowr, it seemed pertinent to determine the effects of 1-hydrazinophthalazine on blood flow through two other large areas, namely, the hepatic-portal (splanchnic minus renal and adrenal) vascular bed and the muscles, and to assess cardiac output changes in hypertensive patients. estimation of hepatic blood flow and cardiac output, arterial pressure was measured directly in the femoral artery, using a strain gage as described elsewhere.9 The pressure in the hepatic vein was measured similarly, the zero point being placed at a level was recorded in the brachial artery by the standard auscultatory method.
RESULTS

I. Cardiac Function and Total Peripheral Resistance
The cardiac output increased markedly in all of the six hypertensive patients studied (table 1, fig. 1 In the remaining normotensive subject there was an increase in muscle blood flow of 14 per cent. Since, in most instances, both arterial pressure and blood flow decreased there probably wsas little or no change in vascular resistunder the fluoroscope or by observing the apex impulse. The increased circulatory rate is not shared by the entire body since the muscles, brain7 and skin" show no appreciable change in blood flow, but is directed primarily through the total splanchnic vascular tree including the crease is accompanied by a tachycardia and a more forceful action of the heart clearly visible kidneys." 2 However, Fazekas recently has found marked increases in cerebral blood flow after Apresoline.'7 An increased venous return is suggested by the slight but definite elevation of hepaticportal venous pressure, right auricular pressure and pulmonary arterial pressure. As a result of the augmented cardiac output after 1 -hydrazinophthalazine, the systolic pressure falls less than with other hypotensive agents; whereas, because of the marked decrease in total peripheral resistance, the diastolic pressure falls considerably more than the systolic.
This pattern of hemodynamic response is similar to that observed during the pyrogenic reaction. Here also, as demonstrated by Bradley, there is a reduction of arterial pressure in hypertensive patients accompanied by marked increases in cardiac output and hepatic-portal and renal blood flows." Bradley has shown in addition that these hemodynamic responses are not dependent on activation of the temperature center, per se, since they occur when the febrile response is blocked by administering aminopyrine. The site of action of pyrogen in producing these hemodynamic responses is unknown, but it seems possible that it may be similar to the site of action of 1Phydrazino-phthalazine. In this connection Gross and his coworkers believe that the drug acts centrally. ' It has been reported from this laboratory'2 as well as by Schroederl" that 1-hydrazinophthalazine and hexamethonium have an additive hypotensive effect. The hemodynamic responses to these agents lend support to this clinical impression. Hexamethonium usually decreases cardiac output as well as right auricular and pulmonary arterial pressures.9 Thus, the combination of markedly decreased peripheral resistance following 1-hydrazinophthalazine and decreased right heart pressures and cardiac output after hexamethonium may have a powerful additive effect in reducing systemic arterial pressure. Moyer has shown in dogs that the increase in cardiac output following 1-hydrazinophthalazine is prevented if hexamethonium is given concurrently.14 The hemodynamic effects of 1-hydrazinophthalazine differ radically from those produced by other hypotensive agents thus far studied. For example, in patients with compensated hearts the cardiac output remains unchanged after veratrum viride15 or dihydroergocornine'6 and usually decreases slightly after hexamethonium.9 Following veratrum there is a generalized rather than regional decrease in peripheral resistance, while after hexamethonium marked vasodilation occurs only in the distal extremities. Following dihydroergocornine there is an increased resistance in the hepaticportal area. After all of these agents (except 1-hydrazinophthalazine) renal blood flow and glomerular filtration rate decrease at least transiently.9' 15, 16 Thus, it seems evident that each of these hypotensive drugs differs somewhat from the others in its effects on blood flow through various areas.
The ideal agent for the treatment of essential hypertension would be one which restores blood flow to normal in those areas in which it has been reduced and which does not disturb otherwise the normal distribution of blood flows or cardiac output. In respect to its ability to increase renal blood flow 1-hydrazinophthalazine would appear to be ideal, but the drug also markedly increases cardiac output to levels which often are above the physiologic range for resting subjects.
SUMMARY AND CONCLUSIONS 1-Hydrazinophthalazine administered to hypertensive and normotensive subjects produced the following hemodynamic effects:
1. The cardiac output increased markedly in hypertensive patients despite a definite reduction in mean arterial pressure. The calculated total peripheral resistance fell sharply.
2. Estimated hepatic-portal blood flow also increased significantly.
3. Blood flow through the muscles (calf segment) usually decreased slightly.
4. The similar hemodynamic patterns produced by 1-hydrazinophthalazine and pyrogen are noted and the pharmacologic basis for the clinically observed additive effects of 1-hydrazinophthalazine and hexamethonium is discussed.
ligeramente. La similaridad entre las respuestas hemodinamicas al 1-hydrazinophthalazine y pirogenos se indica.
